ATGAM equine antithymocyte immunoglobulin 250mg/5mL injection ampoule Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

atgam equine antithymocyte immunoglobulin 250mg/5ml injection ampoule

pfizer australia pty ltd - equine antithymocyte immunoglobulin, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; glycine; hydrochloric acid - indications as at 11 april 2002 : atgam is indicated for renal transplant patients in whom reduction of peripheral t-lympocyte function as measured by rosette-forming cell assay could be desirable. during controlled clinical trials, this immunosuppression has been demonstrated in renal allograft recipients treated with atgam. when it was administered prophylactically with conventional immunosuppressive therapy, atgam delayed the onset of the first rejection episode, and when it was administered at the time of the first rejection, atgam resolved the acute rejection episode more frequently than did conventional therapy alone.

SCANDONEST 2% SPECIAL 2.2mL injection Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

scandonest 2% special 2.2ml injection

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 0.01 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; potassium metabisulfite; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at may 2003: scandonest 2% special is recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

SCANDONEST 2% SPECIAL 1.8mL injection Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

scandonest 2% special 1.8ml injection

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 0.01 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; potassium metabisulfite; disodium edetate; hydrochloric acid; sodium hydroxide - indications as at may 2003: scandonest 2% special is recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

ATO MEPIVACAINE 3% mepivacaine hydrochloride 66mg/2.2mL injection cartridge Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

ato mepivacaine 3% mepivacaine hydrochloride 66mg/2.2ml injection cartridge

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indications as at may 2003: ato mepivacaine 3% is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

LIGNOSPAN SPECIAL 1/80000 2.2mL injection Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

lignospan special 1/80000 2.2ml injection

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; sodium hydroxide; water for injections - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

LIGNOSPAN SPECIAL 1/80000 1.8mL injection Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

lignospan special 1/80000 1.8ml injection

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; water for injections; sodium hydroxide - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

SCANDONEST 3% 66mg/2.2mL injection Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

scandonest 3% 66mg/2.2ml injection

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indications as at may 2003: scandonest 3% is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

SCANDONEST 3% 54mg/1.8mL injection Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

scandonest 3% 54mg/1.8ml injection

specialites septodont pty ltd - mepivacaine hydrochloride, quantity: 30 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indications as at may 2003: scandonest 3% is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

SODIUM NITROPRUSSIDE MEDSURGE sodium nitroprusside 50 mg/2 mL concentrated injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sodium nitroprusside medsurge sodium nitroprusside 50 mg/2 ml concentrated injection vial

medsurge pharma pty ltd - sodium nitroprusside - injection, concentrated - excipient ingredients: water for injections - - immediate reduction of blood pressure in patients with hypertensive crises. concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside. - producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate. - short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. patients should be commenced on oral therapy as soon as possible.

CLEOCIN- clindamycin palmitate hydrochloride granule, for solution Egyesült Államok - angol - NLM (National Library of Medicine)

cleocin- clindamycin palmitate hydrochloride granule, for solution

physicians total care, inc. - clindamycin palmitate hydrochloride (unii: vn9a8jm7m7) (clindamycin - unii:3u02el437c) - clindamycin palmitate hydrochloride 75 mg in 5 ml - cleocin pediatric (clindamycin palmitate hcl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of colitis, as described in the warning box, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). anaerobes: serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and ge